Seventeen health systems have launched the Truveta Genome Project to create what Truveta is calling the largest and most diverse database of genotypic and phenotypic information ever assembled. 

The health systems, with Illumina and Regeneron, have invested $320M in Truveta preferred equity at a valuation exceeding $1 billion, according to Truveta.